|
Epidemiology of Stress and the Metabolic Syndrome Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Epidemiology of Stress and the Metabolic Syndrome conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Epidemiology of Stress and the Metabolic Syndrome Clinical research trials and Epidemiology of Stress and the Metabolic Syndrome healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Epidemiology of Stress and the Metabolic Syndrome. Epidemiology of Stress and the Metabolic Syndrome Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Epidemiology of Stress and the Metabolic Syndrome clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Epidemiology of Stress and the Metabolic Syndrome condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "E" Clinical Trials Conditions > Epidemiology of Stress and the Metabolic Syndrome  Epidemiology of Stress and the Metabolic Syndrome
Epidemiology of Stress and the Metabolic Syndrome
For Condition: Insulin Resistance,Hyperinsulinism,Hypertension,Heart Diseases,Obesity,Metabolic Syndrome X,Cardiovascular Diseases
Status: No longer recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To examine the effects of psychological stress on the metabolic syndrome.
Details: BACKGROUND: The metabolic syndrome identifies the clustering of lipid abnormalities, hypertension, hyperglycemia and abdominal obesity. It is a common and strong contributor to heart disease and diabetes and disproportionably affects older persons. Animal and small clinical studies have suggested that psychosocial stress is a risk factor for the metabolic syndrome. Underlying mechanisms may be through activation of the hypothalamopituitary-adrenal (HPA) axis causing hypercortisolemia, and, partly in turn, elevated inflammation and decreased sex hormone levels. However, longitudinal data showing that psychosocial stress indeed contributes to the onset and sequelae of the metabolic syndrome in the population at large, are lacking. DESIGN NARRATIVE: The primary objectives are to conduct data-analyses and biological sample analyses to examine the effect of psychosocial stress, as indicated by mood problems (depressive symptoms) and stressful social circumstances (poverty, negative life events, occupational stress, lack of emotional support), on the onset and sequelae of the metabolic syndrome. Secondary objectives are to examine underlying biological mechanisms in the effect of psychosocial stress on the metabolic syndrome. The investigators will use available data from two ongoing longitudinal community-based studies among older persons: the Health Aging and Body Composition (Health ABC) study (n=3,075, mean age=74 years, 52%=female, 42% African American) and the InChianti study (n=1,453, mean age=69 years, 56%=female). In both studies psychosocial stress and the metabolic syndrome are well defined, longitudinal data on sequelae (CVD events and diabetes onset) and onset of the metabolic syndrome are available, and potentially underlying biological variables were, or will be, assessed including 24-h urinary cortisol, serum sex steroid hormones (estradiol, testosterone, SHBG, DHEAS) and inflammatory markers (IL-6, IL-10, TNF-alpha, CRP, and various soluble cytokine receptors). The results of this study will help in designing future intervention trials that evaluate whether reducing stress and/or its physiological consequences, either by pharmacological treatment or behavioral intervention, could reduce incidence of the metabolic syndrome in the older general population.
Eligibility:
Study Type: Observational, Natural History, Longitudinal
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
BrendaPenninx, , Wake Forest University
Additional Information:
Study ID Numbers: 1239;
Study Start Date: September 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00073775
Other Hyperinsulinism Studies:
1. Genomewide Search for Loci Underlying Metabolic Syndrome
2. Central Obesity and Disease Risk in Japanese Americans
3. Behavioral Factors in Coronary Heart Disease
4. Genetics of the Metabolic Syndrome in Japanese Americans
5. Genetic Determinants:Low HDL, High Triglycerides, Obesity
Related Studies:
Other Hyperinsulinism Clinical Trials
Other Clinical Trials
Other Clinical Trials
Epidemiology of Stress and the Metabolic Syndrome
|
|
|
|
|
|
|
|
